GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003980 defines the enzymatic activity that adds UDP-glucose to N-linked oligosaccharides (Man7-9GlcNAc2) on incorrectly folded glycoproteins, a key step in endoplasmic reticulum glycoprotein quality control.
• Two human isoforms, UGGT1 (encoded by UGGT1) and UGGT2 (encoded by UGGT2), both possess catalytic activity, though they differ in expression and substrate preference.
• UGGT1 promotes substrate solubility in the endoplasmic reticulum and interacts with the lectin chaperone system to retain misfolded glycoproteins.
• Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation, linking this activity directly to human disease.
• Domain composition, including the catalytic domain and misfold-recognizing domains, regulates UGGT activity and inter-domain motions.
• Switchable glycan probes enable pH-dependent modulation of UGGT activity, offering new tools for studying this enzyme.
Description
UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity, classified under GO:0003980, is a molecular function that catalyzes the addition of UDP-glucose to asparagine-linked (N-linked) oligosaccharides of the form Man7-9GlcNAc2 on incorrectly folded glycoproteins. This enzymatic activity serves as a central sensor in the endoplasmic reticulum (ER) glycoprotein quality control pathway, distinguishing misfolded glycoproteins from properly folded ones and tagging them for further folding attempts or degradation. The reaction is essential for maintaining protein homeostasis in the secretory pathway and has been conserved across eukaryotes, though with notable species-specific differences. Researchers study GO:0003980 because it represents a critical node where protein folding, glycosylation, and ER stress responses intersect. The two human isoforms, UGGT1 and UGGT2, are both enzymatically active but exhibit distinct mRNA expression patterns and enzymatic properties. UGGT1 is the better-characterized isoform and has been shown to promote substrate solubility in the ER, a function that may protect cells from aggregation-related toxicity. Recent structural and biochemical studies have revealed that inter-domain motions in the misfold-recognizing portion of UGGT are essential for its catalytic cycle. Clinically, the importance of this activity is underscored by the discovery that bi-allelic UGGT1 variants cause a congenital disorder of glycosylation, a severe multisystem disease. Additionally, chemical biology approaches using switchable glycan probes have provided new ways to modulate UGGT activity in a pH-dependent manner, opening avenues for therapeutic intervention. Understanding the molecular mechanism, regulation, and disease relevance of GO:0003980 is therefore of broad interest to cell biologists, glycobiologists, and clinicians.
UDP-glucose:glycoprotein glucosyltransferase activity At A Glance
| GO ID | GO:0003980 |
|---|---|
| GO term | UDP-glucose:glycoprotein glucosyltransferase activity |
| Ontology | molecular_function |
| Synonym | UGGT activity |
| Definition | Catalysis of the addition of UDP-glucose on to asparagine-linked (N-linked) oligosaccharides of the form Man7-9GlcNAc2 on incorrectly folded glycoproteins. |
| Major function | Glucose transfer to misfolded glycoproteins as part of ER quality control |
| EC number | 2.4.1.125 (not explicitly in QuickGO but standard) |
| Substrates | UDP-glucose and Man7-9GlcNAc2 N-linked oligosaccharides on misfolded glycoproteins |
| Localization | Endoplasmic reticulum lumen |
What Is GO:0003980?
GO:0003980, UDP-glucose:glycoprotein glucosyltransferase activity, is defined as the catalysis of the addition of UDP-glucose onto asparagine-linked (N-linked) oligosaccharides of the form Man7-9GlcNAc2 on incorrectly folded glycoproteins. In other words, it is the enzymatic activity that transfers glucose from UDP-glucose to a specific set of high-mannose N-glycans that are attached to proteins that have not yet achieved their correct three-dimensional shape. This activity is synonymous with UGGT activity and is a molecular function ontology term.
Why Is UDP-glucose:glycoprotein glucosyltransferase activity Important in Cell Biology?
GO:0003980 is critically important because it defines the enzymatic activity that monitors protein folding in the endoplasmic reticulum and decides whether a glycoprotein should be given additional chances to fold or be targeted for degradation. This activity is essential for proteostasis, and its dysfunction leads to congenital disorders of glycosylation and may contribute to neurodegenerative diseases and cancer progression.
• Central to ER glycoprotein quality control and the calnexin/calreticulin cycle.
• Mutations in UGGT1 cause a congenital disorder of glycosylation with multisystem symptoms.
• UGGT1 promotes substrate solubility, preventing aggregation of misfolded proteins.
• Both UGGT1 and UGGT2 isoforms are enzymatically active, suggesting non-redundant roles.
• Domain composition and inter-domain motions regulate catalytic activity.
• Chemical probes allow pH-dependent modulation of UGGT activity.
• Species differences exist: Schizosaccharomyces pombe has UGGT, but Saccharomyces cerevisiae apparently lacks it.
• UGGT activity is a potential therapeutic target for diseases linked to protein misfolding.
• Research tools like switchable glycan probes enable precise functional studies.
• Understanding UGGT biology aids in engineering glycoproteins for biotechnology.
Molecular Mechanism of UDP-glucose:glycoprotein glucosyltransferase activity
Substrate Recognition and Binding
In simple terms: UGGT first recognizes and binds to misfolded glycoproteins that carry specific N-linked sugars.
UGGT specifically binds to N-linked oligosaccharides of the form Man7-9GlcNAc2 on glycoproteins that are incorrectly folded. The enzyme distinguishes misfolded from native conformations through its misfold-recognizing domains, which undergo conformational changes upon substrate binding. This recognition is essential for the quality control function, as only misfolded glycoproteins are glucosylated.
Catalytic Transfer of Glucose
In simple terms: The enzyme then transfers a glucose molecule from UDP-glucose onto the sugar chain of the misfolded protein.
The catalytic domain of UGGT catalyzes the transfer of glucose from UDP-glucose to the terminal mannose of the Man7-9GlcNAc2 oligosaccharide. Both human isoforms, UGGT1 and UGGT2, possess this catalytic activity, although they may differ in efficiency and substrate preference. The reaction regenerates UDP and produces a glucosylated glycoprotein, which can then re-enter the folding cycle via lectin chaperones.
Domain Composition and Regulation
In simple terms: Different parts of the UGGT protein work together to control when and how the enzyme acts.
UGGT is a multidomain protein, and its domain composition affects catalytic activity. Studies using truncated and chimeric constructs have shown that the catalytic domain and the misfold-recognizing domain cooperate to regulate enzymatic function. Inter-domain motions, including clamping, bending, and twisting, are critical for the catalytic cycle. These dynamic motions allow the enzyme to sample substrate conformations and ensure that only misfolded proteins are glucosylated.
pH-Dependent Modulation by Chemical Probes
In simple terms: New chemical tools can turn UGGT activity up or down depending on the acidity of the environment.
A switchable glycan probe has been developed that enables pH-dependent activity modulation of UGGT through a responsive aglycone. This probe can alter UGGT activity in response to pH changes, providing a novel means to study and potentially manipulate the enzyme in different cellular compartments.
Key Genes Involved in GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
The following genes and proteins are directly involved in or regulate UDP-glucose:glycoprotein glucosyltransferase activity (GO:0003980).
| Gene | Major Role | Research Relevance |
|---|---|---|
| UGGT1 | Encodes the major human UDP-glucose:glycoprotein glucosyltransferase 1 isoform | Most studied isoform; mutations cause congenital disorder of glycosylation |
| UGGT2 | Encodes the human UDP-glucose:glycoprotein glucosyltransferase 2 isoform | Enzymatically active but less characterized; distinct expression pattern |
| CANX | Calnexin, a lectin chaperone that binds glucosylated glycoproteins | Part of the ER quality control cycle with UGGT |
| CALR | Calreticulin, a soluble lectin chaperone | Cooperates with UGGT in glycoprotein folding |
| UGGT1 (S. pombe) | Homolog in Schizosaccharomyces pombe | Used to study UGGT purification and activity |
| UGGT (Drosophila) | Homolog in Drosophila melanogaster | Model for UGGT function in development |
| UGGT (C. elegans) | Homolog in Caenorhabditis elegans | Genetic model for UGGT in ER stress |
| PDIA3 | Protein disulfide isomerase A3 | Interacts with UGGT substrates |
| PDIA6 | Protein disulfide isomerase A6 | May modulate UGGT cycle |
| EDEM1 | ER degradation-enhancing alpha-mannosidase-like protein 1 | Competes with UGGT for misfolded substrates |
| EDEM2 | ER degradation-enhancing alpha-mannosidase-like protein 2 | Involved in ER-associated degradation |
| EDEM3 | ER degradation-enhancing alpha-mannosidase-like protein 3 | Trims mannose from misfolded glycoproteins |
| OS9 | Osteosarcoma amplified 9, an ER lectin | Recognizes misfolded glycoproteins for degradation |
| XTP3-B | ER lectin | Involved in ER quality control |
| SEL1L | Suppressor of lin-12-like | Component of ERAD machinery |
| HRD1 | HMG-CoA reductase degradation 1 | E3 ubiquitin ligase in ERAD |
| BIP | Binding immunoglobulin protein (GRP78) | ER chaperone that assists folding |
| GRP94 | Glucose-regulated protein 94 | ER chaperone for glycoproteins |
How Is UDP-glucose:glycoprotein glucosyltransferase activity Regulated?
UGGT activity is regulated at multiple levels. Transcriptionally, UGGT1 and UGGT2 are induced by ER stress as part of the unfolded protein response (UPR), although the exact mechanisms are not fully detailed in the provided citations. At the protein level, UGGT activity is modulated by inter-domain motions and domain composition. The enzyme's activity can also be influenced by pH, as demonstrated by a switchable glycan probe that modulates UGGT in a pH-dependent manner. Additionally, the availability of substrates and interactions with lectin chaperones like calnexin and calreticulin regulate the cycle.
UDP-glucose:glycoprotein glucosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UGGT1 | Congenital disorder of glycosylation | Patient-derived fibroblasts or iPSCs with UGGT1 mutations |
| UGGT1 | Protein misfolding and aggregation | UGGT1 knockout cell lines treated with aggregation-prone proteins |
| UGGT2 | Unknown; potential modifier | UGGT2 knockout and overexpression models |
| UGGT1/UGGT2 | ER stress-related diseases | ER stress inducers in wild-type and knockout cells |
| UGGT1 | Cancer cell survival | Cancer cell lines with UGGT1 knockdown |
Congenital Disorder of Glycosylation
Bi-allelic variants in UGGT1 cause a congenital disorder of glycosylation, a severe multisystem disease characterized by developmental delay, seizures, and other neurological impairments. This directly links GO:0003980 to human pathology and underscores the importance of UGGT1 function in normal development.
Neurodegenerative Diseases
UGGT1 promotes substrate solubility in the endoplasmic reticulum, suggesting that loss of UGGT function could contribute to protein aggregation diseases such as Alzheimer's or Parkinson's. However, direct evidence in human neurodegeneration is still emerging.
Cancer
Alterations in ER quality control pathways, including UGGT activity, have been implicated in cancer progression and chemoresistance. The role of UGGT in cancer is not fully defined, but its function in proteostasis may support tumor cell survival under stress.
From UDP-glucose:glycoprotein glucosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of UGGT1 loss on glycoprotein folding? | UGGT1 knockout cell lines (e.g., HEK293, HeLa) |
| How do disease-associated UGGT1 mutations affect activity? | Point-mutation knock-in models expressing mutant UGGT1 |
| Can UGGT1 be tagged for localization studies? | Knock-in of fluorescent or epitope tags at the endogenous UGGT1 locus |
| What happens when UGGT1 is overexpressed? | Overexpression cell lines using lentiviral or plasmid vectors |
| Do UGGT1 and UGGT2 have redundant functions? | Double knockout and isoform-specific overexpression models |
| How does pH affect UGGT activity in live cells? | Cells treated with switchable glycan probes |
How to Study the UDP-glucose:glycoprotein glucosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro glucosyltransferase assay | Transfer of glucose from UDP-glucose to acceptor | Enzyme kinetics and inhibitor testing |
| Mass spectrometry | Glycan structures and site occupancy | Confirming Man7-9GlcNAc2 glucosylation |
| Cryo-EM | Three-dimensional structure and conformational changes | Understanding inter-domain motions |
| Switchable glycan probe | pH-dependent activity modulation | Studying UGGT in different pH environments |
| Pulse-chase | Protein folding and degradation kinetics | Assessing UGGT1 role in substrate solubility |
| Immunofluorescence | Subcellular localization | Confirming ER localization of UGGT |
| CRISPR knockout | Loss-of-function phenotypes | Determining UGGT1/UGGT2 necessity |
Enzymatic Activity Assays
UGGT activity can be measured using in vitro assays with radiolabeled UDP-glucose and acceptor glycoproteins. Purification of UGGT from Schizosaccharomyces pombe has been described, providing a source for biochemical studies. Human isoforms can be expressed recombinantly and assayed for catalytic activity.
Structural and Biophysical Methods
Structural studies, including X-ray crystallography and cryo-EM, have revealed inter-domain motions in the misfold-recognizing portion of UGGT. These methods help understand how domain composition affects catalytic activity.
Chemical Biology Probes
Switchable glycan probes enable pH-dependent modulation of UGGT activity, allowing real-time monitoring and manipulation of the enzyme in different environments.
Cell-Based Folding and Solubility Assays
UGGT1 promotes substrate solubility in the ER, which can be assessed using pulse-chase experiments, immunoprecipitation, and solubility fractionation. Knockout and overexpression cell models are valuable for these studies.
How CRISPR Can Be Used to Study GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity
Knockout
CRISPR knockout of UGGT1 or UGGT2 in cell lines such as HEK293 or HeLa can reveal their roles in glycoprotein folding and ER quality control. Knockout models are essential for studying loss-of-function phenotypes, including accumulation of misfolded proteins and activation of ER stress.
Point Mutation
Point mutations identified in patients with congenital disorder of glycosylation can be introduced into the endogenous UGGT1 locus using CRISPR prime editing or homology-directed repair. These models help determine which mutations are pathogenic and how they affect enzymatic activity.
Knock-in
Knock-in of tags (e.g., GFP, HA) at the endogenous UGGT1 or UGGT2 loci allows for real-time imaging and proteomic analysis of the enzymes. This approach preserves native regulation and expression levels.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of UGGT1 or UGGT2 can be used to study gain-of-function effects, such as enhanced substrate solubility or protection against ER stress.
How EDITGENE Supports UDP-glucose:glycoprotein glucosyltransferase activity Research
Researchers studying UDP-glucose:glycoprotein glucosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in glycoprotein folding, ER quality control, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for UDP-glucose:glycoprotein glucosyltransferase activity research.
Frequently Asked Questions About UDP-glucose:glycoprotein glucosyltransferase activity
What is UDP-glucose:glycoprotein glucosyltransferase activity?
It is the enzymatic activity (GO:0003980) that adds glucose from UDP-glucose to N-linked oligosaccharides on misfolded glycoproteins, as part of ER quality control.
What genes encode UDP-glucose:glycoprotein glucosyltransferase?
In humans, the genes are UGGT1 and UGGT2, which encode two enzymatically active isoforms.
What is the function of UGGT1?
UGGT1 promotes substrate solubility in the endoplasmic reticulum and is a key sensor of glycoprotein folding.
What diseases are associated with UGGT1 mutations?
Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation.
How is UGGT activity regulated?
UGGT activity is regulated by domain composition, inter-domain motions, and pH-dependent mechanisms.
What is the difference between UGGT1 and UGGT2?
Both isoforms are enzymatically active, but they differ in mRNA expression patterns and possibly substrate specificity.
Can UGGT activity be measured in vitro?
Yes, using purified enzyme and radiolabeled UDP-glucose with acceptor glycoproteins.
What model organisms are used to study UGGT?
Schizosaccharomyces pombe has been used for purification, while Saccharomyces cerevisiae apparently lacks the enzyme.
What are switchable glycan probes for UGGT?
They are chemical tools that enable pH-dependent modulation of UGGT activity.
How can CRISPR help study UGGT function?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of UGGT1 and UGGT2 genes to study their roles in cells and disease.
Conclusion
UDP-glucose:glycoprotein glucosyltransferase activity (GO:0003980) is a fundamental molecular function in ER glycoprotein quality control, with critical roles in protein folding, disease, and potential therapeutic targeting. The two human isoforms, UGGT1 and UGGT2, are both active, and their dysfunction leads to congenital disorders of glycosylation. Ongoing research using advanced CRISPR models and chemical probes continues to unravel the mechanistic details and regulatory networks of this important enzyme.
References
- 1. Takeda Y et al.. 2014. Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active.. Glycobiology 24(4):344-50 PMID: 24415556
- 2. Takeda Y et al.. 2016. Effects of domain composition on catalytic activity of human UDP-glucose:glycoprotein glucosyltransferases.. Glycobiology 26(9):999-1006 PMID: 27496766
- 3. Hirose M et al.. 2026. Switchable glycan probe enables pH-dependent activity modulation of UDP-glucose: glycoprotein glucosyltransferase through a responsive aglycone.. Chem Commun (Camb) 62(60):14992-14995 PMID: 42385237
- 4. Arnold SM et al.. 2000. Two homologues encoding human UDP-glucose:glycoprotein glucosyltransferase differ in mRNA expression and enzymatic activity.. Biochemistry 39(9):2149-63 PMID: 10694380
- 5. Ferris SP et al.. 2013. UDP-glucose:glycoprotein glucosyltransferase (UGGT1) promotes substrate solubility in the endoplasmic reticulum.. Mol Biol Cell 24(17):2597-608 PMID: 23864712
- 6. Dardas Z et al.. 2025. Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation.. Am J Hum Genet 112(5):1139-1157 PMID: 40267907
- 7. Modenutti CP et al.. 2021. Clamping, bending, and twisting inter-domain motions in the misfold-recognizing portion of UDP-glucose: Glycoprotein glucosyltransferase.. Structure 29(4):357-370.e9 PMID: 33352114
- 8. Fernández FS et al.. 1994. Purification to homogeneity of UDP-glucose:glycoprotein glucosyltransferase from Schizosaccharomyces pombe and apparent absence of the enzyme fro Saccharomyces cerevisiae.. J Biol Chem 269(48):30701-6 PMID: 7982990
